Actofi Pharma And Research Profile
Key Indicators
- Authorised Capital ₹ 8.50 Cr
- Paid Up Capital ₹ 7.63 Cr
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.80 Cr
- Revenue Growth %
- Profit Growth -320.47%
- Ebitda 3595.42%
- Net Worth 876538.85%
- Total Assets 62.30%
About Actofi Pharma And Research
Actofi Pharma And Research Private Limited (APARPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 June 2021 (Three years and eight months 22 days old ). Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.50 Cr and a paid-up capital of Rs 7.63 Cr.
The company currently has active open charges totaling ₹9.80 Cr.
Truptiben Patel, Charmi Radadia, Utsav Patel, and One other member serve as directors at the Company.
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239GJ2021PTC123068
- Company No.
123068
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jun 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Actofi Pharma And Research?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Truptiben Patel  | Director | 03-Jun-2021 | Current |
| Charmi Radadia | Director | 16-Dec-2021 | Current |
| Utsav Patel | Director | 03-Jun-2021 | Current |
| Abhi Agarwal | Director | 11-Jan-2022 | Current |
Financial Performance of Actofi Pharma And Research.
Actofi Pharma And Research Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 320.47% decrease in profit. The company's net worth Soared by an impressive increase of 876538.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Actofi Pharma And Research?
In 2024, Actofi Pharma And Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Millennial Healthcare Private LimitedTruptiben Patel is a mutual person
- Kavach 9 Pharma & Research Private Limited
Charmi Radadia is a mutual person
Charges (Loans)
₹9.80 Cr
₹0
Charges Breakdown by Lending Institutions
- Sidbi : 9.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Aug 2024 | Sidbi | ₹8.00 Cr | Open |
| 27 Aug 2024 | Sidbi | ₹1.80 Cr | Open |
How Many Employees Work at Actofi Pharma And Research?
Actofi Pharma And Research has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Actofi Pharma And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Actofi Pharma And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
